Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LDK378 in Chinese patients with ALK+ NSCLC
NCT02040870Phase 2Completed
- Sponsor
- Novartis
- Start
- Mar 2014
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ceritinib in non-small cell lung cancer (NSCLC), sponsored by Novartis. Started Mar 2014; status: completed.
02
Drugs
ceritinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02040870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02040870.